|
US2020316091A1
|
|
Method for providing contraception
|
|
WO2020048924A1
|
|
Zp3 fragments in immunotherapy of ovarian cancer
|
|
US2019358090A1
|
|
Film applicator assembly
|
|
FR3060389A1
|
|
ENROBE COMPRISING COMPRISING ULIPRISTAL ACETATE OR ONE OF ITS METABOLITES
|
|
US2015018325A1
|
|
Method for late post coital contraception using ulipristal acetate
|
|
US2014235603A1
|
|
Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders
|
|
AU2014230467A1
|
|
Method for scheduling ovulation
|
|
EP2931251A1
|
|
Copper intrauterine device
|
|
MD20150060A2
|
|
Solid dispersion of a selective modulator of the progesterone receptor
|
|
MD20150054A2
|
|
Co-micronisation product comprising a selective progesterone-receptor modulator
|
|
SI2916871T1
|
|
Co-micronisation product comprising ulipristal acetate
|
|
US2015150888A1
|
|
Combination of selective progesterone-receptor modulators and nonsteroidal anti-inflammatory drugs
|
|
WO2011069871A1
|
|
A method for providing emergency contraception using ulipristal acetate
|
|
WO2011091890A1
|
|
A method for post coital contraception in overweight for obese female subjects using ulipristal acetate
|
|
EP2399566A1
|
|
Once-a-month method of contraception
|
|
CN102395373A
|
|
Method for on-demand contraception
|
|
EP2419109A1
|
|
Method for on-demand contraception using levonorgestrel or norgestrel
|
|
AU2009326084A1
|
|
Ulipristal acetate tablets
|
|
KR20150055626A
|
|
Use of ulipristal acetate for treating uterine fibroids
|
|
EP2211845A2
|
|
Glucocorticoid receptor antagonists such as mifepristone for treating cushing's syndrome
|
